Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
MMWR Morb Mortal Wkly Rep ; 67(47): 1305-1309, 2018 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-31199351

RESUMO

Since September 2015, the World Health Organization has recommended antiretroviral therapy (ART) for all persons with human immunodeficiency virus (HIV) infection, regardless of clinical stage or CD4 count (1). This Treat All policy was based on evidence that ART initiation early in HIV infection as opposed to waiting for the CD4 count to decline to certain levels (e.g., <500 cells/mm3, per previous guidelines), was associated with reduced morbidity, mortality, and HIV transmission (2-4). Further, approximately half of persons enrolled in non-ART care that included monitoring for HIV disease progression (i.e., in pre-ART care) were lost to follow-up before becoming ART-eligible (5). India, the country with the third largest number of persons with HIV infection in the world (2.1 million), adopted the Treat All policy on April 28, 2017. This report describes implementation of Treat All during May 2017-June 2018, by India's National AIDS Control Organization (NACO) and partners, by facilitating ART initiation among persons previously in pre-ART care at 46 ART centers supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)* in six districts in the states of Maharashtra and Andhra Pradesh. Partners supported these 46 ART centers in identifying and attempting to contact persons who were enrolled in pre-ART care during January 2014-April 2017, and educating those reached about Treat All. ART center-based records were used to monitor implementation indicators, including ART initiation. A total of 9,898 (39.6%) of 25,007 persons previously enrolled in pre-ART care initiated ART; among these 9,898 persons, 6,315 (63.8%) initiated ART after being reached during May 2017-June 2018, including 1,635 (16.5%) who had been lost to follow-up before ART initiation. NACO scaled up efforts nationwide to build ART centers' capacity to implement Treat All. Active tracking and tracing of persons with HIV infection enrolled in care but not on ART, combined with education about the benefits of early HIV treatment, can facilitate ART initiation.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Atenção à Saúde/organização & administração , Infecções por HIV/tratamento farmacológico , Política de Saúde , Contagem de Linfócito CD4 , Humanos , Índia , Organização Mundial da Saúde
2.
J Int AIDS Soc ; 23(7): e25555, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32618115

RESUMO

INTRODUCTION: India's national AIDS Control Organization implemented World Health Organization's option B+ HIV prevention of mother-to-child transmission (PMTCT) guidelines in 2013. However, scalable strategies to improve uptake of new PMTCT guidelines to reduce new infection rates are needed. This study assessed impact of Mobile Health-Facilitated Behavioral Intervention on the uptake of PMTCT services. METHODS: A cluster-randomized trial of a mobile health (mHealth)-supported behavioural training intervention targeting outreach workers (ORWs) was conducted in four districts of Maharashtra, India. Clusters (one Integrated Counselling and Testing Center (ICTC, n = 119), all affiliated ORWs (n = 116) and their assigned HIV-positive pregnant/postpartum clients (n = 1191)) were randomized to standard-of-care (SOC) ORW training vs. the COMmunity home Based INDia (COMBIND) intervention - specialized behavioural training plus a tablet-based mHealth application to support ORW-patient communication and patient engagement in HIV care. Impact on uptake of maternal antiretroviral therapy at delivery, exclusive breastfeeding at six months, infant nevirapine prophylaxis, and early infant diagnosis at six months was assessed using multi-level random-effects logistic regression models. RESULTS: Of 1191 HIV-positive pregnant/postpartum women, 884 were eligible for primary outcome assessment; 487 were randomized to COMBIND. Multivariable analyses identified no statistically significant differences in any primary outcome by study arm. COMBIND was associated with higher uptake of exclusive breastfeeding at two months (adjusted Odds Ratio (aOR), 2.10; 95% CI 1.06 to 4.15) and early infant diagnosis at six weeks (aOR, 2.19; 95% CI 1.05 to 3.98) than SOC. CONCLUSIONS: The COMBIND intervention was easily integrated into India's existing PMTCT programme and improved early uptake of two PMTCT components that require self-motivated health-seeking behaviour, thus providing preliminary evidence to support COMBIND as a potentially scalable PMTCT strategy. Further study would identify modifications needed to optimize other PMTCT outcomes.


Assuntos
Terapia Comportamental , Aleitamento Materno , Agentes Comunitários de Saúde/educação , Infecções por HIV/diagnóstico , Telemedicina , Adulto , Fármacos Anti-HIV/uso terapêutico , Análise por Conglomerados , Aconselhamento , Diagnóstico Precoce , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/transmissão , Humanos , Índia , Lactente , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Nevirapina/uso terapêutico , Gravidez
3.
Bull World Health Organ ; 86(3): 221-8, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18368210

RESUMO

The immunization service delivery support (ISDS) model was initiated in Andhra Pradesh, India, in November 2003 with the aim of strengthening immunization services through supportive supervision. The ISDS model involves a well-established supervision system built upon the existing health infrastructure. The objectives of this approach are to: (1) identify areas of high performance and those that need improvement, (2) assist staff in identifying and correcting wrong practices, (3) improve staff skills, (4) motivate staff, and (5) initiate corrective actions at appropriate levels through information sharing. An evaluation of cost and effectiveness of ISDS in 16 districts that participated in the programme found that the incremental cost associated with three rounds of supportive supervision visits was approximately US$ 110,630 (US$ 36,877 per round). The performance of health centre and immunization sessions was evaluated using 43- and 28-point checklists, respectively, and demonstrated significant improvement during and following the two-year implementation of ISDS. The average percentage change in health centre performance scores from baseline to the fourth round of evaluation was approximately 36%, and immunization session performance scores increased by an average of 9%. The incremental costs per additional per cent increase in average health centre performance score and per additional per cent increase in average immunization session performance score over the evaluation period were estimated to be US$ 3091 and US$ 12,760, respectively. The incremental cost-effectiveness ratios are relatively sensitive to personnel and travel costs. Integration of ISDS into the Andhra Pradesh immunization system is projected to result in a 39% potential cost savings per round of supervision visit.


Assuntos
Infecções Bacterianas/prevenção & controle , Programas de Imunização/economia , Programas de Imunização/organização & administração , Infecções Bacterianas/imunologia , Análise Custo-Benefício/métodos , Vacina contra Difteria, Tétano e Coqueluche/uso terapêutico , Humanos , Índia , Modelos Organizacionais , Estudos de Casos Organizacionais/economia
4.
PLoS One ; 13(9): e0203425, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30180186

RESUMO

BACKGROUND: The Prevention of Mother-to-Child Transmission of HIV (PMTCT) program in India is one of the largest in the world. It uses outreach workers (ORWs) to facilitate patient uptake of services, however, the challenges faced by the ORWs, and their views about the effectiveness of this program are unknown. METHODS: The COMmunity-Home Based INDia (COMBIND) Prevention of Mother to Child Transmission of HIV study evaluated an integrated mobile health and behavioral intervention to enhance the capacity of ORWs in India. To understand the challenges faced by ORWs, and their perceptions of opportunities for program improvement, four group discussions were conducted among 60 ORW from four districts of Maharashtra, India, as part of the baseline assessment for COMBIND. Data were qualitatively analyzed using a thematic approach. RESULTS: Numerous personal-, social-, and structural-level challenges existed for ORW as they engaged with their patients. Personal-level challenges for ORWs included disclosure of their own HIV status and travelling costs for home visits. Personal-level challenges for patients included financial costs of travelling to ART centers, non-adherence to ART, loss of daily wages, non-affordability of infant formula, lack of awareness of the baby's needs, financial dependence on family, four time points (6weeks, 6 months, 12 months and 18 months) for HIV tests, and need for nevirapine (NVP) prophylaxis. Social-level challenges included lack of motivation by patients and/or health care staff, social stigma, and rude behavior of health care staff and their unwillingness to provide maternity services to women in the PMTCT programme. Structural-level challenges included cultural norms around infant feeding, shortages of HIV testing kits, shortages of antiretroviral drugs and infant NVP prophylaxis, and lack of training/knowledge related to PMTCT infant feeding guidelines by hospital staff. The consensus among ORWs was that there was a critical need for tools and training to improve their capacity to effectively engage with patients, and deliver appropriate care, and for motivation through periodic feedback. CONCLUSIONS: Given the significant challenges in PMTCT programme implementation reported by ORW, novel strategies to address these challenges are urgently needed to improve patient engagement, and access to and retention in care.


Assuntos
Infecções por HIV , Transmissão Vertical de Doenças Infecciosas , Programas Nacionais de Saúde , Serviços Preventivos de Saúde , Adulto , Antirretrovirais/administração & dosagem , Antirretrovirais/economia , Custos e Análise de Custo , Feminino , Infecções por HIV/economia , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , Humanos , Índia/epidemiologia , Transmissão Vertical de Doenças Infecciosas/economia , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Programas Nacionais de Saúde/economia , Programas Nacionais de Saúde/organização & administração , Gravidez , Serviços Preventivos de Saúde/economia , Serviços Preventivos de Saúde/organização & administração
5.
Indian J Public Health ; 48(2): 49-56, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15709584

RESUMO

Japanese encephalitis is demonstrated to be a significant public health problem in India and throughout Asia. JE primarily affects children between the ages of one and 15 years. Of those who contract the disease, approximately 70% either die or are left with a long-term neurological disability. JE vaccines have existed for a very long time, however due to cost and unstable supply, they have not been able to meet the needs of developing country health systems. In addition, alternative JE control measures have proven insufficient to control disease. As a result, 68 percent of babies born in the poorest countries of Asia are at risk for JE. Against this background, future directions for JE activities in India include control through vaccination when an affordable vaccine is available (at risk areas), strengthening surveillance data on disease patterns including age and geographic distribution, involvement of the private sector and incorporation of newer diagnostics as they become available and to focus on control efforts and prevent this debilitating disease now and in the future. Recent work, both internationally and in India, offers hope to help solve this public health problem and protect children from this disease.


Assuntos
Encefalite Japonesa/epidemiologia , Encefalite Japonesa/diagnóstico , Encefalite Japonesa/prevenção & controle , Humanos , Índia/epidemiologia , Vigilância da População
6.
J Indian Med Assoc ; 103(4): 212, 214, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16173427

RESUMO

Injection means the administration of a substance into the skin, subcutaneous tissue, muscle tissue or vein. So far the information is available, it is found that a major proportion of injections administered in India are unsafe. Technique of injection and faulty habits are the reasons of unsafe injections. Intravenous, intramuscular, subcutaneous are most frequently used parenteral routes. Different needle positions while administering injections, preferred site, size and-length of the needle are all discussed while safe injection practices are taken into consideration.


Assuntos
Injeções/métodos , Segurança , Patógenos Transmitidos pelo Sangue , Guias como Assunto , Humanos , Índia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa